See highlights from GHTC's 2023 Innovating for Impact Awards

Search the GHTC website

News: Advocacy action

News
USAID
October 28, 2019

GHTC sends letter urging Congressional appropriators to include report language on BARDA in FY20 bill

GHTC sent a letter to House and Senate appropriators urging them to include in the final fiscal year (FY) 2020 Labor, Health and Human Services, Education, and Related Agencies bill report language emphasizing the role of the Biomedical Advanced Research and Development Authority (BARDA) in advancing R&D for naturally-occurring health threats and requesting a delineation of BARDA’s investments in this area in its annual five-year budget plan. 

Read time: 4 minutes / PDF link
PATH/Ruhani Kaur
October 24, 2019

GHTC endorses letter calling for robust TB funding in FY20 appropriations bill

GHTC endorsed a letter from the TB Roundtable to House and Senate appropriators urging the adoption of robust funding levels for tuberculosis (TB) programs at the US Agency for International Development and Centers for Disease Control and Prevention in final fiscal year 2020 (FY20) appropriations bills. The letter also urges appropriators to restore TB as a disease eligible for funding under the Department of Defense’s Peer Reviewed Medical Research Program.

Read time: 4 minutes / PDF link
National Institute of Allergy and Infectious Diseases, National Institutes of Health
October 24, 2019

GHTC endorses letter urging robust funding for NIH in FY20 appropriations bill

GHTC endorsed a letter from the Ad Hoc Group for Medical Research urging House and Senate appropriators to work quickly to adopt a meaningful increase to the fiscal year 2020 (FY20) Labor, Health and Human Services, Education, and Related Agencies appropriations bill and provide a robust funding increase for the National Institutes of Health.

Read time: 2 minutes / PDF link
PATH/Gabe Bienczycki
October 24, 2019

GHTC responds to RFI on National Vaccine Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI) on the 2020 National Vaccine Action Plan (NVP). GHTC’s submission encouraged the continuation of R&D objectives reflected in the 2010 NVP and recommended additional areas of focus including strengthening public-private partnerships, advancing regulatory science, ensuring sustainable financing for areas that lack commercial market demand, promoting access-centered R&D, and collaborating with international partners to strengthen laboratory and clinical trial capacity.

Read time: 6 minutes / PDF link